Madame Bioscience PCL (BKK:MADAME)
Thailand flag Thailand · Delayed Price · Currency is THB
1.010
0.00 (0.00%)
Last updated: Sep 3, 2026, 10:41 AM ICT

Madame Bioscience PCL Financials Overview

Millions THB. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,5831,4782,1232,3022,2281,862
Revenue Growth
-9.72%-30.39%-7.78%3.35%19.61%22.79%
Gross Profit
449.89321.76359.99296.4481.33301.34
Operating Income
-398.37-185.4342.34-166.26-385.44-110.1
Net Income
-141.0645.77-331.63-405.81-422.31-152.43
Earnings Per Share
-0.180.06-0.54-0.66-0.70-0.38
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Packaging Business
-83.2957.56847.96845.1659.43
Selling Skincare Products Business
350.89197.02----
Food Business
1,2481,2721,4791,7761,7401,198
Other Business
0.380.992.042.664.4817.28
Elimination
-15.43-75.32-315.66-324.48-361.58-12.65
Total
1,5831,4782,1232,3022,2281,862

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
156.69193.8180.6234.76253.3452.39
Total Debt
218.08243.62614.14819.66921.92323.17
Net Cash (Debt)
-61.39-49.81-533.52-784.91-668.57-270.78
Net Cash Growth
------
Net Cash Per Share
-0.08-0.06-0.86-1.28-1.11-0.68

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
37.3539.72227.0171.98-163.44-98.48
Capital Expenditures
-47.3-41.49-15.39-39.61-144.02-206.38
Free Cash Flow
-9.94-1.77211.6232.37-307.46-304.86
Free Cash Flow Growth
--553.65%---

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
28.42%21.77%16.96%12.88%3.65%16.18%
Operating Margin
-25.16%-12.55%1.99%-7.22%-17.30%-5.91%
Pretax Margin
-9.62%3.38%-15.52%-17.79%-19.94%-10.07%
Profit Margin
-8.91%3.10%-15.62%-17.63%-18.96%-8.19%
FCF Margin
-0.63%-0.12%9.97%1.41%-13.80%-16.37%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-12.36----
P/FCF Ratio
--3.5735.16--
PS Ratio
0.520.380.360.490.931.40